| Original language | English |
|---|---|
| Pages (from-to) | 2044-2047 |
| Number of pages | 4 |
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Volume | 78 |
| Issue number | 7 |
| Early online date | 2023 |
| DOIs |
|
| Publication status | Published - Jul 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, No. 7, 07.2023, p. 2044-2047.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis
AU - Haasnoot, Maria L.
AU - Kleuskens, Mirelle T. A.
AU - Lopez-Rincon, Alejandro
AU - Diks, Mara A. P.
AU - Terreehorst, Ingrid
AU - Akkerdaas, Jaap H.
AU - van Ree, Ronald
AU - van Ampting, Marleen T. J.
AU - Garssen, Johan
AU - Redegeld, Frank A.
AU - van Esch, Betty C. A. M.
AU - Bredenoord, Albert J.
N1 - Funding Information: This research is funded within the Partnership between NWO domain Applied and Engineered Sciences and Danone Nutricia Research and with additional financial support from Topsector Agri and Food, project number 16495 with the acronym LOIRE. AJB is supported by Vidi grant 91718300 from the Netherlands Organization for Scientific Research NWO. Funding Information: AJB received research funding from Norgine, Thelial, SST and received speaker and/or consulting fees from Laborie, Arena, EsoCap, Medtronic, Dr. Falk Pharma, Calypso Biotech, Alimentiv, Sanofi, Reckett, Regeneron and AstraZeneca (all unrelated to this work). RvR received consultancy fees from HAL Allergy, Citeq, Angany, Reacta Healthcare, Mission MightyMe and AB Enzymes, speaker fees from HAL Allergy, ThermoFisher Scientific and ALK, and has stock option of Angany (all unrelated to this work). MTJVA is employed by Danone Nutricia Research. JG and BCAMVE are partly employed by Danone Nutricia Research. All other authors report no conflict of interest. Funding Information: AJB received research funding from Norgine, Thelial, SST and received speaker and/or consulting fees from Laborie, Arena, EsoCap, Medtronic, Dr. Falk Pharma, Calypso Biotech, Alimentiv, Sanofi, Reckett, Regeneron and AstraZeneca (all unrelated to this work). RvR received consultancy fees from HAL Allergy, Citeq, Angany, Reacta Healthcare, Mission MightyMe and AB Enzymes, speaker fees from HAL Allergy, ThermoFisher Scientific and ALK, and has stock option of Angany (all unrelated to this work). MTJVA is employed by Danone Nutricia Research. JG and BCAMVE are partly employed by Danone Nutricia Research. All other authors report no conflict of interest. This research is funded within the Partnership between NWO domain Applied and Engineered Sciences and Danone Nutricia Research and with additional financial support from Topsector Agri and Food, project number 16495 with the acronym LOIRE. AJB is supported by Vidi grant 91718300 from the Netherlands Organization for Scientific Research NWO.
PY - 2023/7
Y1 - 2023/7
UR - http://www.scopus.com/inward/record.url?scp=85150609942&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/all.15694
DO - https://doi.org/10.1111/all.15694
M3 - Comment/Letter to the editor
C2 - 36869622
SN - 0105-4538
VL - 78
SP - 2044
EP - 2047
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 7
ER -